The Johnson and Johnson lawsuit is one of the largest mass tort cases in American history. As of 2026, more than 100,000 claims remain active against J&J. Most of them involve talcum powder linked to ovarian cancer and mesothelioma.
The company's attempts to use bankruptcy to limit payouts have failed twice in federal court. That means individual claims are moving forward. Jury trials are scheduled, and settlement talks are intensifying.
This article covers every active J&J lawsuit category in 2026. You'll find updated settlement amounts, payout estimates, eligibility rules, filing deadlines, and step-by-step instructions for joining a claim. Whether you used baby powder for decades or received a J&J hip implant, the information here applies to you.
One fact worth knowing right now: J&J set aside $8.9 billion in its most recent settlement proposal. Courts rejected the structure, but that money signals where payouts could land.
Johnson and Johnson Lawsuit
The Johnson and Johnson lawsuit refers to tens of thousands of legal claims filed against the consumer health giant. These cases allege that J&J sold products it knew were dangerous. The largest group of claims involves talcum powder contaminated with asbestos.
Lawsuits also target J&J's hip implants, its antipsychotic drug Risperdal, and its surgical mesh products. Each product line has its own litigation track. Some have already produced settlements worth billions.
| Lawsuit Category | Number of Claims | Status in 2026 |
|---|---|---|
| Talcum Powder (Cancer) | 100,000+ | Active, trials ongoing |
| Hip Implants (ASR/Pinnacle) | 10,000+ | Mostly settled |
| Risperdal (Gynecomastia) | 9,000+ | Partially settled |
| Surgical Mesh (Ethicon) | 30,000+ | Most claims resolved |
J&J is now a different company structurally than it was five years ago. It spun off its consumer health division into Kenvue Inc. in 2023. But J&J retained liability for the talc lawsuits.
The core accusation across all cases is the same. J&J allegedly put profits over safety and hid evidence of harm from the public.
Johnson and Johnson Lawsuit Update 2026
The biggest development in 2026 is the collapse of J&J's bankruptcy shield strategy. The company created a subsidiary called Red River Talc LLC in 2023 and pushed it into bankruptcy. This was the second attempt after the first subsidiary, LTL Management LLC, failed the same way.
In early 2025, the Third Circuit Court of Appeals rejected this second bankruptcy filing. The court ruled that Red River Talc did not face genuine financial distress. J&J appealed to the U.S. Supreme Court, which declined to hear the case.
That means talc lawsuits are back in regular courts. Bellwether trials are being scheduled in the MDL No. 2738 in the District of New Jersey. Several state court cases are also moving forward.
Key 2026 Developments:
- Supreme Court refused to review the Third Circuit's ruling
- J&J announced willingness to negotiate a global settlement
- New bellwether trials set for mid-to-late 2026
- Company reported $8.9 billion earmarked for talc resolution
The legal pressure on J&J is higher than it has ever been. Without bankruptcy protection, the company faces the prospect of individual jury trials. Some prior talc verdicts have topped $2 billion in a single case.
Johnson and Johnson Class Action Lawsuit
A Johnson and Johnson class action lawsuit allows a group of people with similar injuries to sue together. However, most J&J cases are not true class actions. They are mass torts consolidated into multidistrict litigation.
The difference matters. In a class action, one outcome applies to everyone. In mass tort MDL, each case is evaluated individually. Your payout depends on your specific diagnosis, exposure history, and evidence.
| Feature | Class Action | Mass Tort (MDL) |
|---|---|---|
| Individual evaluation | No | Yes |
| One settlement for all | Yes | No |
| Payout varies per person | Rarely | Yes |
| Common in J&J talc cases | No | Yes |
Some smaller J&J cases have used class action structures. A few consumer fraud claims related to talc marketing were filed as class actions in state courts. But the cancer claims are handled as individual cases within the MDL.
If you hear "class action" used casually about J&J lawsuits, it usually means the MDL. The distinction is important because mass tort cases often produce larger individual payouts.
Key Takeaway: Johnson and Johnson faces over 100,000 active claims in 2026, its bankruptcy strategy has failed, and most cases are individual mass tort claims within an MDL, not traditional class actions.
Johnson and Johnson Baby Powder Lawsuit
The Johnson and Johnson baby powder lawsuit is the centerpiece of the entire J&J litigation. Plaintiffs claim that J&J's iconic baby powder contained trace amounts of asbestos for decades. Internal company documents suggest J&J knew about contamination as early as the 1970s.
J&J pulled talc-based baby powder from U.S. shelves in 2020. By 2023, it switched to a cornstarch formula globally. The company maintained that its talc was safe, but the product change told a different story.
Key Facts About the Baby Powder Lawsuit:
- Product sold for over 100 years before discontinuation
- Reuters investigation in 2018 revealed internal J&J memos about asbestos
- FDA testing in 2019 found asbestos in a single bottle of baby powder
- J&J stopped all talc-based baby powder sales worldwide in 2023
The baby powder lawsuits fall into two main categories. Some plaintiffs developed ovarian cancer after using the powder for feminine hygiene. Others developed mesothelioma from inhaling talc fibers during regular use.
Think of it like this: one product, two different types of cancer claims, and thousands of people affected by each. The baby powder lawsuit is the engine driving everything else in the J&J litigation.
J&J Talc Lawsuit
The J&J talc lawsuit is broader than just baby powder. It covers all talc-containing products sold by Johnson and Johnson. This includes Shower to Shower, cosmetic talc products, and industrial talc supplies.
Talc is a mineral mined from the earth. The problem is that talc deposits often sit near asbestos deposits underground. Cross-contamination during mining means asbestos fibers can end up in finished consumer products.
| Talc Product | Years Sold | Cancer Link |
|---|---|---|
| Johnson's Baby Powder | 1894 to 2023 | Ovarian cancer, mesothelioma |
| Shower to Shower | 1960s to 2012 (sold to Valeant) | Ovarian cancer |
| Cosmetic talc products | Various | Mesothelioma |
The MDL for talc cases sits in the U.S. District Court for the District of New Jersey. Judge Freda Wolfson oversees the consolidated proceedings. As of early 2026, more than 61,000 cases are pending in this MDL alone.
Thousands more are filed in state courts across Missouri, California, New Jersey, and other states. Some of the largest verdicts in American legal history came from Missouri state court talc trials.
Johnson and Johnson Ovarian Cancer Lawsuit
The Johnson and Johnson ovarian cancer lawsuit involves women who developed ovarian cancer after long-term use of talc-based products for feminine hygiene. Studies have shown a 20% to 33% increased risk of ovarian cancer among regular perineal talc users.
Most plaintiffs in these cases used baby powder or Shower to Shower for years or decades. They applied the product directly to the genital area or on underwear and sanitary pads.
Notable Ovarian Cancer Verdicts:
- $4.69 billion verdict in St. Louis, Missouri (2018), later reduced to $2.12 billion on appeal; 22 plaintiffs
- $750 million verdict in New Jersey (2024), single plaintiff case
- $120 million verdict in California (2019), single plaintiff
These jury awards send a clear signal. When juries see J&J's internal documents, they tend to side with plaintiffs. The company's own research showed awareness of asbestos risks.
Not every ovarian cancer case involves talc exposure, of course. But for women who used these products regularly for 10 years or more, the connection has been strong enough to win at trial repeatedly. Oncologists and epidemiologists have testified about the biological pathway linking talc particles to ovarian tissue inflammation and cancer.
Key Takeaway: J&J talc lawsuits cover multiple products beyond baby powder, ovarian cancer claims have produced jury verdicts exceeding $2 billion, and over 61,000 cases are pending in the federal MDL alone.
Johnson and Johnson Mesothelioma Lawsuit
The Johnson and Johnson mesothelioma lawsuit involves plaintiffs who developed this rare and aggressive cancer after inhaling asbestos-contaminated talc. Mesothelioma is almost exclusively caused by asbestos exposure. When it shows up in a talc user, the connection is hard to dispute.
Mesothelioma cases tend to produce higher individual payouts than ovarian cancer cases. The disease is nearly always fatal. Median survival time after diagnosis is 12 to 21 months.
| Factor | Mesothelioma Cases | Ovarian Cancer Cases |
|---|---|---|
| Cause | Asbestos fibers in talc | Talc particles in ovarian tissue |
| Average verdict | $10M to $50M+ | $5M to $100M+ |
| Survival rate | Very low | Varies by stage |
| Number of claims | Smaller subset | Majority of talc claims |
Some mesothelioma plaintiffs were not just consumers. They include people who worked in talc mines, cosmetics factories, or barbershops where talc was used daily.
A 2026 reality: many mesothelioma plaintiffs are elderly or have already passed away. Their estates or surviving family members continue the lawsuits. Courts often expedite these cases because of the terminal nature of the disease.
J&J has lost several mesothelioma trials convincingly. In one New Jersey case, a jury awarded $117 million to a single plaintiff who used baby powder for decades.
Johnson and Johnson Settlement
The Johnson and Johnson settlement landscape in 2026 is complicated. J&J proposed a global settlement worth $8.9 billion to resolve all talc claims. This proposal was tied to its bankruptcy strategy through Red River Talc.
When courts rejected the bankruptcy plan, that settlement structure fell apart. But the dollar figure remains a benchmark. J&J has publicly stated it wants a "comprehensive resolution" for talc claims.
Settlement History by Product:
- Hip Implants (ASR): $2.5 billion settlement in 2013 covering about 8,000 claims
- Hip Implants (Pinnacle): Individual settlements, total exceeding $1 billion
- Risperdal: Approximately $800 million in total settlements
- Surgical Mesh (Ethicon): Settlements totaling over $700 million
- Talc Powder: No global settlement reached yet; individual verdicts and settlements ongoing
The talc settlement is the big one everyone is watching. Without a bankruptcy framework, J&J may need to negotiate directly with plaintiff attorneys or face hundreds of trials.
Some legal experts predict a new settlement offer in late 2026 or early 2027. The number could be higher than $8.9 billion because J&J lost its leverage when the bankruptcy strategy collapsed.
Johnson and Johnson Lawsuit Settlement Amounts
Johnson and Johnson lawsuit settlement amounts vary widely based on the product, the injury, and the strength of each case. There is no single number that applies to everyone.
For talc cases, no global settlement exists yet. Individual cases that go to trial have produced wildly different results. Some plaintiffs received nothing. Others received billions.
| Case Type | Low Estimate | High Estimate | Typical Range |
|---|---|---|---|
| Ovarian cancer (strong evidence) | $100,000 | $100,000,000+ | $500,000 to $5,000,000 |
| Mesothelioma | $500,000 | $117,000,000+ | $1,000,000 to $20,000,000 |
| Hip implant (ASR) | $50,000 | $500,000 | $200,000 to $350,000 |
| Risperdal (gynecomastia) | $10,000 | $8,000,000 | $50,000 to $500,000 |
| Surgical mesh | $25,000 | $250,000 | $50,000 to $150,000 |
These ranges are based on past verdicts and settlements. Your individual amount depends on several factors.
What affects your settlement amount:
- Type and severity of your diagnosis
- Length and frequency of product use
- Strength of medical evidence linking the product to your condition
- Your age and lost income
- Whether punitive damages apply
Settlement amounts in mass tort cases are not like lottery prizes. They reflect real damages. Medical bills, lost wages, pain and suffering, and punitive penalties all factor in.
Key Takeaway: Settlement amounts range from tens of thousands to hundreds of millions of dollars depending on the product, diagnosis, and individual case strength, with talc mesothelioma cases producing the largest awards.
Johnson and Johnson Lawsuit How Much Will I Get
How much you will get from a Johnson and Johnson lawsuit depends on your specific situation. Nobody can guarantee an exact dollar amount before your case is evaluated.
That said, there are realistic ranges based on years of verdicts and settlements. If J&J reaches a global talc settlement, the per-claimant payout would likely be much lower than individual trial verdicts. Think of it like the difference between a retail price and a wholesale price.
If J&J settles globally at $8.9 billion for 100,000+ claimants:
- Average payout per claimant: roughly $50,000 to $89,000
- Higher-tier claims (mesothelioma, strong evidence): $200,000 to $1,000,000+
- Lower-tier claims (weaker evidence, less severe diagnosis): $5,000 to $50,000
These are estimates based on similar mass tort settlements. The actual numbers will depend on how the settlement fund gets divided.
Factors that push your payout higher:
- Mesothelioma diagnosis (vs. ovarian cancer)
- Decades of product use with documentation
- Strong medical records connecting talc to your cancer
- Significant lost income or earning capacity
- Age at diagnosis (younger plaintiffs often receive more)
If you want the maximum amount, your medical records and product use history are everything. Keep every receipt, every medical report, every purchase record you can find.
Johnson and Johnson Talc Settlement 2026
The Johnson and Johnson talc settlement in 2026 is still being negotiated. No final deal is in place as of this writing. But the pressure to settle has never been stronger.
After the bankruptcy strategy failed, J&J faces a simple reality. Going to trial 100,000 times would cost billions in legal fees alone. Settling is cheaper and more predictable.
Talc Settlement Timeline:
| Event | Date |
|---|---|
| First talc lawsuits filed | 2013 |
| LTL Management bankruptcy (1st attempt) | October 2021 |
| Third Circuit dismisses LTL bankruptcy | January 2023 |
| Red River Talc bankruptcy (2nd attempt) | September 2023 |
| Third Circuit dismisses Red River Talc | 2025 |
| Supreme Court declines review | 2025 |
| New settlement negotiations | Ongoing in 2026 |
| Expected settlement framework | Late 2026 to early 2027 |
Some plaintiff attorneys have publicly called for a settlement of $10 billion or more. They argue the $8.9 billion offer was too low given the number of claimants and the severity of their injuries.
J&J's market capitalization exceeds $370 billion. A $10 billion settlement would represent less than 3% of the company's value. Wall Street analysts have largely priced talc liability into J&J's stock already.
The most likely outcome in 2026 is a framework agreement. Final payouts would follow over 3 to 5 years after a deal is reached.
Who Qualifies for Johnson and Johnson Lawsuit
You qualify for a Johnson and Johnson lawsuit if you used a J&J talc product and later developed cancer, or if you were harmed by another J&J product like a hip implant or Risperdal.
Eligibility requirements differ by lawsuit category. Here are the basics.
Talc Lawsuit Eligibility:
- Used Johnson's Baby Powder, Shower to Shower, or another J&J talc product
- Used the product regularly for at least one year (longer use strengthens your case)
- Diagnosed with ovarian cancer, mesothelioma, endometrial cancer, or another linked condition
- Can provide medical records confirming the diagnosis
Hip Implant Eligibility:
- Received a J&J ASR XL or Pinnacle hip implant
- Experienced device failure, revision surgery, metallosis, or chronic pain
Risperdal Eligibility:
- Took Risperdal (risperidone) and developed gynecomastia (male breast growth)
- Took the drug as a minor
Who does NOT qualify:
- People who used talc products but have no cancer diagnosis
- People whose cancer has no plausible link to talc (for example, lung cancer in a non-smoker with no asbestos exposure)
- Claims where the statute of limitations has expired with no exceptions
Family members of deceased talc users may file wrongful death claims. The estate of a person who died from talc-related cancer can pursue the lawsuit on their behalf.
Key Takeaway: Eligibility requires a documented diagnosis linked to a specific J&J product, and family members of deceased users can file wrongful death claims on behalf of their loved ones.
How to File Johnson and Johnson Lawsuit
Filing a Johnson and Johnson lawsuit in 2026 involves several steps. The process is not complicated, but it requires organization and documentation.
Step-by-Step Filing Process:
- Gather your medical records. Get every document related to your cancer diagnosis or product injury. Pathology reports, imaging results, and treatment records are all important.
- Document your product use. Write down how long you used J&J products, how often, and which specific products. Old photos, purchase receipts, and even family testimony help.
- Contact a mass tort attorney. Most J&J lawsuit attorneys work on contingency. That means you pay nothing upfront. They collect a percentage (typically 33% to 40%) of your settlement or verdict.
- Your attorney files the complaint. The case enters either the federal MDL in New Jersey or a state court depending on your location and circumstances.
- Case evaluation and discovery. Your medical records and product history are reviewed. Expert witnesses may be retained.
- Settlement negotiation or trial. Most cases settle. A small percentage go to trial.
| Filing Detail | Info |
|---|---|
| Cost to file | $0 upfront (contingency fee) |
| Attorney fee | 33% to 40% of recovery |
| Where cases are filed | MDL No. 2738 (NJ) or state courts |
| Time from filing to resolution | 1 to 4 years typically |
You don't need to do this alone. An experienced attorney handles the legal work. Your job is to provide the medical and product use documentation.
Johnson and Johnson Class Action Settlement 2026
A Johnson and Johnson class action settlement in 2026 would resolve large groups of claims at once. While most J&J talc cases are individual mass tort claims, a settlement structure could function like a class action in practice.
Here's what that means. J&J could create a settlement fund and establish criteria for claim categories. Claimants would submit proof, get assigned a tier, and receive a payout based on their tier.
Potential Settlement Tier Structure (Estimated):
| Tier | Criteria | Estimated Payout |
|---|---|---|
| Tier 1 (Highest) | Mesothelioma, death, strong evidence | $500,000 to $2,000,000+ |
| Tier 2 | Ovarian cancer, long-term use, clear link | $100,000 to $500,000 |
| Tier 3 | Ovarian cancer, moderate evidence | $25,000 to $100,000 |
| Tier 4 (Lowest) | Weaker evidence, shorter use period | $5,000 to $25,000 |
This tiered approach is standard in mass tort settlements. It was used in the J&J hip implant settlement and in many pharmaceutical cases.
If a settlement is announced in 2026, claimants would likely have 90 to 180 days to file their claims. There would be a claims administrator, a special master, and a review process.
No settlement has been finalized yet. But legal observers expect a framework to emerge after the bellwether trials produce more data points. Every trial verdict gives both sides better information for negotiations.
Johnson and Johnson Hip Implant Lawsuit
The Johnson and Johnson hip implant lawsuit involves two main product lines: the ASR XL Acetabular System and the Pinnacle Hip Implant System. Both were made by J&J's subsidiary DePuy Orthopaedics.
The ASR hip was recalled in 2010 after failure rates hit nearly 40% within five years. J&J agreed to a $2.5 billion settlement in 2013 covering roughly 8,000 ASR claimants.
Pinnacle hip cases went to trial:
- $502 million verdict in Dallas (2016), five plaintiffs
- $247 million verdict in Dallas (2017), six plaintiffs
- $1.04 billion verdict in Dallas (2017), reduced on appeal, six plaintiffs
The metal-on-metal design caused metallosis in many patients. Tiny metal particles shed from the device and poisoned surrounding tissue. Symptoms included chronic pain, swelling, difficulty walking, and the need for revision surgery.
| Hip Implant Detail | ASR XL | Pinnacle |
|---|---|---|
| Recalled | 2010 | Not recalled |
| Settlement | $2.5B global | Individual settlements |
| Main defect | High failure rate | Metal debris |
| Revision surgery needed | Yes (many patients) | Yes (many patients) |
By 2026, most ASR cases are resolved. Some Pinnacle cases remain active. If you received either implant and experienced problems, you may still have a viable claim, but time is running out.
Key Takeaway: J&J's hip implant lawsuits have produced over $4 billion in settlements and verdicts combined, with ASR cases mostly resolved and some Pinnacle claims still active in 2026.
Johnson and Johnson Risperdal Lawsuit
The Johnson and Johnson Risperdal lawsuit involves young men and boys who developed gynecomastia after taking the antipsychotic drug. Gynecomastia is the abnormal growth of breast tissue in males. It can require surgical removal and causes significant emotional distress.
J&J marketed Risperdal aggressively for off-label uses in children. The company failed to adequately warn about the gynecomastia risk. Internal documents showed J&J knew about the breast growth side effect.
Notable Risperdal Verdicts:
- $8 billion punitive damages verdict in Philadelphia (2019), reduced to $6.8 million on appeal
- $70 million verdict in Philadelphia (2015), single plaintiff
- $2.5 million verdict in Philadelphia (2015), single plaintiff
The $8 billion verdict grabbed headlines, but the massive reduction on appeal is typical. Courts often reduce punitive damages using constitutional guidelines.
J&J's subsidiary Janssen Pharmaceuticals paid $2.2 billion in 2013 to settle federal criminal and civil charges related to Risperdal marketing. The company admitted to promoting the drug for uses not approved by the FDA.
By 2026, most Risperdal cases have been resolved through settlements or trials. A small number of claims remain pending. If you or your child took Risperdal and experienced gynecomastia, you should check whether your state's statute of limitations still allows filing.
Johnson and Johnson Bankruptcy Lawsuit
The Johnson and Johnson bankruptcy lawsuit refers to J&J's controversial strategy of using subsidiary bankruptcies to limit talc payouts. This approach is known as the "Texas two-step" because it originated with companies incorporated in Texas.
Here's how it worked. J&J created a subsidiary and transferred all talc liabilities to it. Then the subsidiary filed for Chapter 11 bankruptcy. This was supposed to freeze all talc lawsuits and force claimants into a bankruptcy settlement.
The bankruptcy timeline:
- October 2021: LTL Management LLC created and filed for bankruptcy
- January 2023: Third Circuit dismissed LTL's bankruptcy as not filed in good faith
- April 2023: LTL dissolved; J&J regrouped
- September 2023: Red River Talc LLC created and filed for bankruptcy
- 2025: Third Circuit dismissed Red River Talc's bankruptcy
- 2025: U.S. Supreme Court declined to hear J&J's appeal
- 2026: All talc claims return to regular courts
The strategy was simple but aggressive. J&J, worth over $370 billion, tried to cap talc payouts at $8.9 billion by routing everything through a technically "bankrupt" entity.
Courts saw through it. The Third Circuit ruled that these subsidiaries were not in real financial distress. They were shells designed to avoid jury trials. The ruling was a major win for talc claimants.
What this means for you: the bankruptcy shield is gone. Your case will be heard in a regular court. That gives plaintiffs more leverage in settlement talks because J&J now faces the risk of massive jury verdicts.
Johnson and Johnson Lawsuit Deadline
The Johnson and Johnson lawsuit deadline depends on where you live and what type of claim you have. Each state has its own statute of limitations for personal injury and product liability cases.
For most talc cancer claims, the clock starts ticking when you receive your diagnosis. This is called the "discovery rule." You don't need to have known about the connection to talc at the time of diagnosis in most states.
Statute of Limitations by State (Selected Examples):
| State | Personal Injury Deadline | Wrongful Death Deadline |
|---|---|---|
| California | 2 years from discovery | 2 years from death |
| New York | 3 years from discovery | 2 years from death |
| New Jersey | 2 years from discovery | 2 years from death |
| Texas | 2 years from discovery | 2 years from death |
| Missouri | 5 years from discovery | 3 years from death |
| Florida | 2 years from discovery | 2 years from death |
| Illinois | 2 years from discovery | 2 years from death |
Important exceptions:
- Minors typically get extra time. The clock may not start until they turn 18.
- Some states toll (pause) the statute of limitations during bankruptcy proceedings. Since J&J's bankruptcy strategy ran from 2021 to 2025, your deadline may have been extended.
- Wrongful death claims have separate deadlines from personal injury claims.
Do not wait. Even if you think you might still have time, filing sooner is always better. Evidence gets lost. Witnesses become unavailable. Medical records disappear. If you have a potential claim, talk to an attorney now.
The filing deadline is the single most important date in your case. Miss it, and nothing else matters.
Key Takeaway: Filing deadlines vary by state and claim type, with most allowing 2 to 5 years from the date of diagnosis, and delays caused by J&J's bankruptcy proceedings may have extended some deadlines.
Frequently Asked Questions
How much will I get from the Johnson and Johnson lawsuit?
Most talc claimants could receive between $50,000 and $500,000 in a global settlement scenario.
Mesothelioma cases and strong ovarian cancer claims could receive over $1 million.
The exact amount depends on your diagnosis, product use history, and the strength of your evidence.
Is there a deadline to file a Johnson and Johnson lawsuit?
Yes, every state has a statute of limitations, typically 2 to 5 years from the date of diagnosis.
The discovery rule applies in most states, meaning the clock starts when you learn of your condition.
Filing sooner is always better because evidence and witnesses become harder to find over time.
Does the Johnson and Johnson class action lawsuit include baby powder?
Yes, baby powder is the primary product involved in the J&J talc litigation.
Most baby powder claims are handled as individual mass tort cases within MDL No. 2738 in New Jersey.
Both ovarian cancer and mesothelioma claims related to baby powder are included.
Who qualifies for the Johnson and Johnson talc settlement?
You qualify if you regularly used a J&J talc product and were diagnosed with ovarian cancer, mesothelioma, or another linked cancer.
Family members can file wrongful death claims for deceased users.
You must have medical records confirming your diagnosis and evidence of product use.
Did Johnson and Johnson file bankruptcy to avoid paying lawsuits?
J&J did not file bankruptcy itself, but it created two subsidiary companies and filed them for bankruptcy.
LTL Management LLC and Red River Talc LLC were both created to absorb talc liabilities and cap payouts.
Federal courts rejected both bankruptcy filings, ruling they were not filed in good faith, and all claims have returned to regular courts.
This is the most significant consumer product lawsuit in a generation. Over 100,000 people are waiting for resolution. J&J's legal shields have been stripped away, and settlement pressure is building.
If you used J&J talcum powder products and developed cancer, check your eligibility now. Gather your medical records and contact an attorney before your state's filing deadline passes.
The window to act is open. Don't let it close.
